TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Interaction Details
01. General Information
Pair Name Amentoflavone, Sorafenib
Phytochemical Name Amentoflavone (PubChem CID: 5281600 )
Anticancer drug Name Sorafenib (PubChem CID: 216239 )
Structure of
Phytochemical
2D-img
Download
2D MOL 3D MOL
Structure of
Anticancer Drug
2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Enhancing Drug Efficacy
Hide/Show
Combination Pair ID: 95
Pair Name Amentoflavone, Sorafenib
Disease Info [ICD-11: 2B51] Osteosarcoma Investigative
Biological Phenomena Induction-->Apoptosis
Gene Regulation Down-regulation Expression CFLAR hsa8837
Down-regulation Phosphorylation MAPK1 hsa5594
Down-regulation Expression MMP9 hsa4318
Down-regulation Phosphorylation NFKB1 hsa4790
Down-regulation Expression VEGFA hsa7422
Down-regulation Expression XIAP hsa331
In Vitro Model U2OS Osteosarcoma Homo sapiens (Human) CVCL_0042
Result Amentoflavone may sensitize OS to sorafenib treatment by inducing intrinsic and extrinsic apoptosis and inhibiting ERK/NF-κB signaling transduction.
Combination Pair ID: 649
Pair Name Amentoflavone, Sorafenib
Disease Info [ICD-11: 2C12] Hepatocellular carcinoma Investigative
Biological Phenomena Induction-->Apoptosis
Gene Regulation Down-regulation Expression CASP3 hsa836
Down-regulation Expression CASP8 hsa841
Down-regulation Expression CASP9 hsa842
Down-regulation Expression CFLAR hsa8837
Down-regulation Phosphorylation MAPK3 hsa5595
Down-regulation Expression MCL1 hsa4170
Down-regulation Expression XIAP hsa331
In Vitro Model SK-HEP-1 Liver and intrahepatic bile duct epithelial neoplasm Homo sapiens (Human) CVCL_0525
In Vivo Model To establish the animal model, 1×10⁷ SK-Hep1 cells were suspended in 150 ul mix-ture of serum-free DMEM and matrigel (2: 1) and inoculated subcutaneously in the right legs of nude mice.
Result Our results demonstrated that amentoflavone significantly enhanced sorafenib-inhibited tumor growth and expression of ERK/AKT phosphorylation and anti-apoptotic proteins compared to single-agent treatment. Additionally, amentoflavone also triggered sorafenib-induced apoptosis through extrinsic and intrinsic apoptotic pathways.
Reversing Drug Resistance
Hide/Show
Combination Pair ID: 650
Pair Name Amentoflavone, Sorafenib
Disease Info [ICD-11: 2C12] Hepatocellular carcinoma Investigative
Biological Phenomena Induction-->Apoptosis
Gene Regulation Up-regulation Cleavage CASP3 hsa836
Up-regulation Cleavage CASP8 hsa841
Down-regulation Expression CFLAR hsa8837
Down-regulation Expression MCL1 hsa4170
Down-regulation Expression XIAP hsa331
In Vitro Model SK-HEP-1 Liver and intrahepatic bile duct epithelial neoplasm Homo sapiens (Human) CVCL_0525
Result Amentoflavone not only reversed sorafenib-induced anti-apoptotic protein levels but also enhanced sorafenib-induced pro-apoptotic protein expression in SK-Hep1R cells. In conclusion, amentoflavone may be used as a sorafenib sensitizer to enhance sorafenib-induced cytotoxicity and trigger sorafenib-induced apoptosis through extrinsic and intrinsic pathways in SK-Hep1R cells.
03. Reference
No. Title Href
1 Reinforcement of Sorafenib Anti-osteosarcoma Effect by Amentoflavone Is Associated With the Induction of Apoptosis and Inactivation of ERK/NF-κB. In Vivo. 2022 May-Jun;36(3):1136-1143. doi: 10.21873/invivo.12812. Click
2 Amentoflavone Enhances the Therapeutic Efficacy of Sorafenib by Inhibiting Anti-apoptotic Potential and Potentiating Apoptosis in Hepatocellular Carcinoma In Vivo. Anticancer Res. 2018 Apr;38(4):2119-2125. doi: 10.21873/anticanres.12452. Click
3 Amentoflavone enhances sorafenib-induced apoptosis through extrinsic and intrinsic pathways in sorafenib-resistant hepatocellular carcinoma SK-Hep1 cells in vitro. Oncol Lett. 2017 Sep;14(3):3229-3234. doi: 10.3892/ol.2017.6540. Click
It has been 46717 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP